TOP - October 2011 Vol 4, No 7
WASHINGTON, DC—Psychosocial stress may play a role in the etiology of breast cancer aggressiveness, particularly among minority populations, according to study results. In a cross-sectional study, greater levels of fear, anxiety, or isolation were found to be associated with more aggressive breast cancer; however, no clear driver for the association is yet identified.
In the September issue, we published an article entitled Patients Want to Discuss Cost of Cancer Care, Oncologists Often Avoid It. We wondered if patients were talking to their pharmacists about the cost of their oncology drugs.
Here’s how our online reading community responded:
- 14%indicated they are never asked about drug costs
- 48%said patients occasionally talk to them about drug costs
- 38% are regularly talking with patients about drug costs
Many cancer survivors who thought they were fertile now may be finding that is not the case. New research is suggesting that current estimates of the impact of chemotherapy on women’s reproductive health are too low.
Researchers at the University of California San Francisco (UCSF) say their analysis of the age-specific, longterm effects of chemotherapy provides new insights that will help patients and clinicians make more informed de cisions about future reproductive options, such as egg harvesting (Cancer. September 1, 2011. Epub ahead of print).
I will admit that I am knowingly and willingly walking into a hornet’s nest by discussing the current drug shortage, but I feel I must. In addition to our (oncology pharmacists’) ruminations about the current drug shortage, the issue has garnered national media attention. Major newspapers, national TV networks, magazines, and numerous websites have jumped on the drug shortage story.
SAN FRANCISCO—A number of interventions can help reduce breast cancer among women at high risk, but uptake is sluggish, and there can be confusion about which agent to prescribe to a given patient. Seema Khan, MD, professor of surgery at Northwestern University Feinberg School of Medicine, Chicago, addressed the topic of pharmacologic risk reduction at the 2011 Breast Cancer Symposium.
Results 11 - 18 of 18